Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5355)
All Articles published online
|
Publishing Process of This Article
|
Jan 28, 2022 (publication date) through Dec 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Demirli Atici S, Kamer E. Is CA19-9 effective in predicting chemotherapeutic response in patients with synchronous liver metastases with colorectal cancer? World J Gastroenterol 2022; 28(4): 500-501 [PMID: 35125833 DOI: 10.3748/wjg.v28.i4.500] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Demirli Atici S, Kamer E. Is CA19-9 effective in predicting chemotherapeutic response in patients with synchronous liver metastases with colorectal cancer? World J Gastroenterol 2022; 28(4): 500-501 [PMID: 35125833 DOI: 10.3748/wjg.v28.i4.500] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i4/500.htm |
| Number | Citing Articles |
| 1 |
Chen Shen, Wen Gu, Xiaojun Zhou. WITHDRAWN: Characterization of mutational landscape reveals influencing factors for therapeutic response and prognosis of colorectal cancer patients with synchronous liver metastases underwent simultaneous resection of primary and metastatic lesions. Surgery Open Science 2024; doi: 10.1016/j.sopen.2023.12.004
|
| 2 |
Chen Shen, Wen Gu, Xiaojun Zhou. The mutational factors influencing the therapeutic response and prognosis of stage IV CRC patients undergoing simultaneous resection of primary and liver metastatic lesions and subsequent adjuvant therapy---A pilot study on the prognosis of stage IV CRC. Arab Journal of Gastroenterology 2025; doi: 10.1016/j.ajg.2025.09.026
|
| 3 |
Yun-Jie Hao, Lu-Wey Chang, Chih-Yung Yang, Liang-Chuan Lo, Chien-Ping Lin, Yuan-Wei Jian, Jeng-Kai Jiang, Fan-Gang Tseng. The rare circulating tumor microemboli as a biomarker contributes to predicting early colorectal cancer recurrences after medical treatment. Translational Research 2024; 263: 1 doi: 10.1016/j.trsl.2023.07.011
|